XP6-25328-64451
3 vaccinations
4 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 551 / MN
- Registered
- 2022-07-20
- Relationship
- Child or adolescent in my care
- Guardian
- Z54-44798-78608
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-19
Dose 1 — Moderna
-
2022-07-20
Registered in v-safe
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-08-02
-
2022-08-09
Survey response — day 21, dose 1, under 3MedDRA: Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Unexplained fever for 36 hoursMedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Survey response — day 28, dose 1, under 3MedDRA: Cough, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion and associated cough with nasal drip.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Dose 2 — Moderna
- 2022-08-23
-
2022-08-24
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-08-25
- 2022-08-26
- 2022-08-27
- 2022-08-28
- 2022-08-29
- 2022-08-30
- 2022-09-06
- 2022-09-13
- 2022-09-20
-
2022-09-27
Survey response — day 35, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
- 2022-11-22
-
2023-02-07
Dose 3 — Moderna
- 2023-02-21
-
2023-03-22
Survey response — day 42, dose 3, under 3MedDRA: Respiratory failure, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-03-22
Report sent to call center — day 42, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-03-23
- 2023-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-19 | Moderna | No |
| 2 | 2022-08-23 | Moderna | No |
| 3 | 2023-02-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-22 | Unsuccessful |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Unexplained fever for 36 hours
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Congestion and associated cough with nasal drip.
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Runny nose, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory failure | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release